Compromised RXR-γ levels are also reported in several malignancies including non-small cell lung cancer [31]; where it also has been reported that epigenetic silencing of RXR-γ correlated with decreased overall survival of patients [32]. Here, RXRG is linked to non-small cell lung carcinoma.